{{Rsnum
|rsid=1150793
|Gene=MSH5
|Chromosome=6
|position=31749919
|Orientation=minus
|GMAF=0.09596
|Gene_s=MSH5
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.0 | 6.2 | 93.8
| HCB | 0.7 | 16.8 | 82.5
| JPT | 0.0 | 1.8 | 98.2
| YRI | 12.9 | 42.9 | 44.2
| ASW | 0.0 | 26.3 | 73.7
| CHB | 0.7 | 16.8 | 82.5
| CHD | 0.0 | 15.6 | 84.4
| GIH | 0.0 | 18.8 | 81.2
| LWK | 1.8 | 31.8 | 66.4
| MEX | 0.0 | 15.5 | 84.5
| MKK | 0.6 | 17.4 | 81.9
| TSI | 0.0 | 19.6 | 80.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=21815799
|Title=Major histocompatibility complex class I chain-related gene polymorphisms: associated with susceptibility to Kawasaki disease and coronary artery aneurysms
}}

{{PMID|15743917|OA=1
}} HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol.

{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}